Core Viewpoint - The article highlights various high-paying job opportunities in the scientific instrument sector, emphasizing the demand for skilled sales professionals and engineers in different regions of China [2]. Group 1: Job Opportunities - Agilent Technologies (China) is hiring a Channel Sales Manager in Shanghai with a salary range of 18k-28k and 13 months of salary [4]. - Pano is looking for a Regional Manager in Chengdu with a salary range of 20k-30k and 13 months of salary [6]. - Relying on the sales experience in the laboratory industry is preferred for various positions, indicating a strong market for experienced professionals [3][5]. Group 2: Job Requirements - Candidates for the Channel Sales Manager position at Agilent should have 3-5 years of channel management experience and a bachelor's degree in a related field [3]. - The Regional Manager at Pano requires familiarity with industrial online gas chromatography and at least 3 years of sales management experience [5]. - Positions such as Sales Engineer and Application Engineer require relevant educational backgrounds and experience in scientific instruments, with specific skills in communication and teamwork emphasized [12][20]. Group 3: Salary Insights - The salary ranges for various positions vary significantly, with some roles offering up to 30k per month, indicating a competitive market for skilled professionals [4][6][17]. - Positions like Sales Manager at Relying offer salaries between 10k-15k, reflecting the diversity in compensation based on experience and role [7]. Group 4: Industry Trends - There is a notable demand for professionals with experience in specific sectors such as pharmaceuticals, environmental testing, and chemical analysis, suggesting growth in these areas [18][22]. - The article indicates a trend towards hiring individuals with strong sales capabilities and technical knowledge, particularly in the scientific instrument field [10][30].

特别提示 微信机制调整，点击顶部"仪器信息网" → 右上方"…" → 设为 ★ 星标，否则很可能无法看到我们的推送。 近日， 海关系统发布 14 项 仪器试剂耗材 采购意向，预算总额达 1.06亿 元，涉及气相色谱仪、液相色谱仪、气相 色谱-三重四极杆质谱仪、超高效液相色谱三重四极杆质谱仪、原子荧光形态分析仪、梯度PCR仪、膳食纤维测定仪 等，预计采购时间为202 5 年 8~10 月。 部分采购仪器简介： 手持式X荧光光谱分析仪 手持式X荧光光谱分析仪（Handheld X-ray Fluorescence Spectrometer）是一种便携式元素分析设备，通过X 射线激发样品中的原子，使其发射特征X射线荧光，从而快速、无损地确定样品的元素组成和含量 。 X荧光光谱、 XRF（能量色散型X荧光光谱仪） 超景深显微镜 超景深显微镜是一种通过特殊光学设计和图像处理技术，实现大景深范围内清晰成像的显微镜。 数码显微镜 全自动酶免仪 全自动酶免仪（全自动酶免分析仪）是一种基于酶联免疫吸附试验（ELISA）原理的自动化检测设备，可全自动完成 样本处理、试剂加样、温育、洗板、结果分析等全流程操作。 详细清单： 导读： ...

Core Viewpoint - Corning Inc. reported record high core sales and core earnings per share for Q2 2025, indicating strong performance and growth potential in the market [2][3]. Financial Performance - Core sales increased by 12% year-over-year [3] - Core operating margin expanded by 160 basis points [3] - Core earnings per share grew by 28% year-over-year [3] - Adjusted free cash flow rose by 28% year-over-year [3] Business Segments - The optical communications segment saw an 81% year-over-year increase in sales, driven by strong demand for generative AI products [3]. Future Outlook - Management anticipates continued strong performance in Q3, with core sales expected to achieve double-digit year-over-year growth, reaching $4.2 billion [3]. - Core earnings per share are projected to be between $0.63 and $0.67 [3].

Core Insights - The article highlights the recent procurement data for PCR instruments, indicating a significant increase in the number of units awarded compared to the previous week, despite a decrease in total monetary value [3]. Group 1: Procurement Overview - A total of 10 procurement items related to PCR instruments were recorded in the 30th week of 2025 (July 21 - July 27), with 45 units awarded, representing a 36.4% increase from the previous week [3]. - The total monetary value for the awarded units was 3.714 million yuan, which is a 55.3% decrease from the previous week [3]. Group 2: Brand Performance - Among the brands, Thermo Fisher won 5 units of fluorescent quantitative PCR instruments, while Bole, Borui, and Huasheng each secured 1 unit, with an average winning price of 390,200 yuan per unit [3][5]. Group 3: Detailed Procurement Data - The detailed procurement data includes various institutions and the specific models of PCR instruments purchased, with notable entries such as: - Foshan Second People's Hospital purchased 2 units of Thermo Fisher's QuantStudio™3/FQD-96C at 300,000 yuan each [5]. - Guangzhou University of Chinese Medicine acquired 2 units of Thermo Fisher's QuantStudio 5 at 500,000 yuan each [5]. - Beijing Liver Disease Research Institute purchased 1 unit of Thermo Fisher's QuantStudio6pro at 785,000 yuan [5]. Group 4: Procurement Types - The breakdown of procurement types shows: - 35 units of PCR instruments totaling 512,800 yuan - 8 units of fluorescent quantitative PCR instruments totaling 3,121,600 yuan - 2 units of gradient PCR instruments totaling 79,400 yuan [7].

Core Viewpoint - Bio-Rad has launched four next-generation droplet digital PCR (ddPCR) platforms, redefining research standards and providing new solutions for laboratories worldwide [1][3]. Product Launch - The four new instruments include the QX Continuum™ ddPCR system and the QX700™ series ddPCR platforms, which were developed following the acquisition of Stilla Technologies [3][6]. QX Continuum™ ddPCR System - The QX Continuum™ ddPCR system is designed for translational research applications, featuring a user-friendly workflow similar to qPCR, with integrated performance and flexibility, and the capability for multiplex detection with up to eight independent thermal cycling programs per plate [5]. QX700™ Series - The QX700™ series includes three new ddPCR instruments: QX700™ HT ddPCR system, QX700™ S ddPCR system, and QX700™ E ddPCR system. This series supports seven-color multiplex detection, processes over 700 samples daily, requires minimal input volume, and features user-friendly software for data interpretation [6][9]. Expanded Product Line - The expanded product line, including over 400,000 test kits, enhances Bio-Rad's influence in genomics research and application science, solidifying its leadership in droplet digital PCR solutions [6][10]. Four Core Technological Breakthroughs 1. **Superior Detection Performance**: The new ddPCR systems utilize advanced optical detection and droplet generation technologies, providing high sensitivity and precise quantification, even for low-abundance samples [6][7]. 2. **Reliable and Stable Data**: Optimized algorithms and a comprehensive quality control system reduce variability between samples and replicate experiments, ensuring high reproducibility and credibility of results [7][8]. 3. **Efficient Multiplex Detection**: The systems support simultaneous detection of multiple targets, enhancing throughput while streamlining manual processes, significantly improving laboratory efficiency [9][10]. 4. **Wide Application Adaptability**: The four differentiated ddPCR systems cater to the needs of small research teams and large laboratories, providing tailored solutions for various research directions and accelerating scientific output [10][11]. User Feedback - Users have praised Bio-Rad's ddPCR technology for its ability to directly count molecules without relying on standard curves, highlighting its strong detection capabilities, especially for trace DNA analysis. The intuitive software interface and simplified workflow design have also been positively received, reducing the potential for operational errors [11].

Core Insights - The article discusses the recent government procurement intentions for laboratory instruments, highlighting a total of 28 items with a budget of 213 million yuan [2][3]. Procurement Overview - The procurement includes various advanced instruments such as small animal MRI, nanofiber prototype machines, ultracentrifuges, high-content imaging systems, and 300kV cryo-electron microscopes, with expected procurement dates between August and December 2025 [3][4]. - The total budget for these instruments is 213 million yuan, indicating significant investment in biomedical research capabilities [2][3]. Instrument Details - **Small Animal MRI**: Designed for high-precision imaging of small animals, widely used in biomedical research [3][4]. - **Nanofiber Prototype Machine**: Aimed at producing nanofibers, with a budget of 5 million yuan [4][6]. - **Ultracentrifuge**: Capable of speeds exceeding 100,000 rpm, featuring advanced monitoring and control systems [6][7]. - **High-Content Imaging System**: Equipped with multiple laser sources and advanced imaging capabilities, budgeted at 400 million yuan [6][7]. - **300kV Cryo-Electron Microscope**: Designed for structural analysis of biological macromolecules, with a budget of 4.5 million yuan [6][7]. Additional Instruments - **High-Throughput Sequencer**: Expected to process large volumes of samples efficiently, with a capacity of 300-600Gb/run [7][8]. - **Automated Nucleic Acid Analyzer**: Integrates extraction, amplification, and analysis processes, ensuring high-quality results [7][8]. - **Mass Spectrometry Equipment**: Aimed at protein identification and analysis, with a budget of 1.25 million yuan [7][8]. - **Liquid Chromatography Systems**: Two units planned for procurement, designed to meet high-pressure and flow rate requirements [7][8]. Conclusion - The procurement intentions reflect a strategic focus on enhancing research capabilities in the biomedical field, with substantial investments in advanced laboratory instruments [2][3][4].

Core Viewpoint - The article discusses the 2026 Regional Joint Fund (Beijing) project guidelines, focusing on key industries in Haidian District and Beijing Economic-Technological Development Area, with specific funding allocations for integrated and key projects [1][8]. Group 1: Key Areas of Focus - The guidelines emphasize several key areas for funding, including: - Electronic Information: Integrated circuits, artificial intelligence, wireless communication, and quantum information [2][3]. - Life and Health: Synthetic biology manufacturing, cell and gene therapy, brain science, biomedical engineering, and smart healthcare [3]. - New Materials and Advanced Manufacturing: Robotics, new materials, and intelligent equipment [3]. - Modern Transportation and Aerospace: New energy and intelligent connected vehicles, and aerospace industry [3]. Group 2: Guidelines Requirements - The guidelines require that the proposed needs must meet specific criteria: - Scientific focus on fundamental scientific issues behind technological challenges, avoiding mere technical applications [4]. - Inclusivity without overly restrictive elements, ensuring a balance between specificity and broad applicability [5]. - Directionality that aligns closely with the development needs of Haidian District and Beijing Economic-Technological Development Area [5]. - Safety compliance with national laws and ethical standards, emphasizing the prevention of biological and information security risks [6]. - Innovation to avoid duplication with existing guidelines from national and municipal science funds [6]. Group 3: Submission Requirements - Proposers must meet certain conditions: - The proposing unit must be a supporting unit of the Beijing Natural Science Foundation [7]. - Experience in leading key national science fund projects is required [8]. - Each proposer can submit only one guideline request, and each company can participate in up to two requests [8].

导读： 国家自然科学基金公布了2025年度青年科学基金项目（A类，含延续资助项目）和青年科学基金项目（B类）项目资助结果！ 特别提示 微信机制调整，点击顶部"仪器信息网" → 右上方"…" → 设为 ★ 星标，否则很可能无法看到我们的推送。 国家自然科学基金公布了2025年度青年科学基金项目（A类，含延续资助项目）和青年科学基金项目（B类）项目资助结果！ 项目申请人可以进入国家自然科学基金委的项目信息管理系统查询 （菜单：查询与统计 —— 项目信息查询 —— 批准项目综合查询） ， 如 查 询不到或者有其他疑问，也可以咨询请依托单位管理员并协助查询。 发 文 不易 ， 请 帮 小编 点 下 "❤️" | 来 源 ： 仪 器 信 息 网 | 译 者 ： 蔡 蔡 | 责 编 ： 安 安 | 视 觉 ： 长 艳 柱 子 | 版 权 ： 本 文 部 分 素 材 源 自 网 络 ， 版 权 归 原 作 者 所 有 ， 观 点 代 表 作 者 本 人 ， 不 代 表 本 号 立 场 | 转 载 ： 须 本 号 授 权 ， 请 联 系 主 编 ...

Core Viewpoint - The Ministry of Industry and Information Technology will promote the integration of technological innovation and industry in the second half of 2025, focusing on core technology breakthroughs and industrial chain security in high-end instruments and meters [2][4]. Group 1: Policy Directions - The first policy direction is to promote the integration of technological innovation and industry, with a focus on key core technology breakthroughs in high-end instruments and meters, such as high-precision sensors and intelligent detection equipment [5][6]. - The second direction involves improving the industrial policy system, which includes developing special support policies covering the entire R&D, production, and application chain, such as tax incentives and financial support [7][8]. - The third direction emphasizes strengthening industrial chain security, ensuring stable supply of strategic mineral resources necessary for high-end instrument manufacturing [9][10]. Group 2: Implementation Measures - The implementation measures include building technology innovation platforms and incubators to support high-end instrument startups with technology, funding, and market access [11]. - Financial and market support will be expanded through low-interest loans and government procurement policies to prioritize domestic high-end instruments [12]. - Digital transformation will be promoted by integrating artificial intelligence with manufacturing to develop new products and services [13][14]. - The establishment of standards and certification systems will enhance product quality consistency and support international certifications to improve export competitiveness [15][16].

特别提示 微信机制调整，点击顶部"仪器信息网" → 右上方"…" → 设为 ★ 星标，否则很可能无法看到我们的推送。 2025年7⽉7⽇，上海第三人民中级法院公开终结强制清算公告。 公告称： 就 上海川岭仪器仪表合作公司 破产清算一案，因客观上无法进行全面清算，本院应清算组申请，依照《中 华人民共和国公司法》第二百三十九条之规定，于 2 0 2 5年5月8日裁定终结破产程序。 上海市第三中级人民法院 民事 裁 定 书 (2025) 沪 03 强清 61 号之一 申请人:上海川岭仪器仪表合作公司清算组。 组长:沈紫华。 2025年2月5日,上海川岭仪器仪表合作公司(以下简称川 岭公司)清算组向本院提交清算报告,称川岭公司已停止经营, 清算组除接管到川岭公司都分证照、坦章、财务账册、原始会计 凭证等资料外,未接管到任何财产,截至报告时所有税收债权均 已清偿完毕,无社保债权,亦无任何债权人申报债权。鉴于川岭 公司无任何财产,客观上无法进行全面清算,且该公司无法清偿 强制清算费用,已符合终结强制清算程序的法定条件。 本院认为,川岭公司清算组的清算报告依法可予确认,鉴于 川岭公司清算组虽然接管到川岭公司部分证照、印章、 ...